India’s First FSSAI-Approved Postbiotic Innovation

Akums introduces a next-generation postbiotic formulation designed to redefine gut and immune wellness in India. Built on clinically validated fermentation science, this advanced solution offers better stability, faster functionality, and modern nutraceutical advantages for evolving consumer needs. With the India gut health market valued at ₹3,200 Cr and growing at 14% YoY, brands now have an opportunity to lead the future beyond traditional probiotics. The formulation starts working within 2 hours, while being FSSAI Approved and backed by certified quality standards for trust, safety, and efficacy.

The Problem

70–80% of immune function lives in the gut.
Most brands ignore this.

Probiotics were a breakthrough in 2005. By 2025, they're table stakes — commoditised, low-margin, and clinically limited. The probiotic category has four cracks no formulation fix can paper over.

2 Week Lag Before Any Effect

2-Week Lag Before Any Effect

Probiotics must colonise and proliferate before delivering benefit. Consumers quit before they feel anything. Clinical dropout rates exceed 40% in the first month.

Gastric Acid Destroys Live Cultures

Gastric Acid Destroys Live Cultures

Up to 99.9% of probiotic CFUs are destroyed before reaching the colon. Enteric coating helps, but survival rates remain unpredictable across individuals and conditions.

Cold Chain Dependency

Cold Chain Dependency

Live bacteria degrade without refrigeration — creating supply chain complexity, higher COGS, shorter shelf life, and distribution constraints across India's diverse climate zones.

Cold Chain Dependency

Zero Regulatory Differentiation

Every competitor ships a 10-billion CFU lactobacillus capsule. There is no meaningful formulation moat. Price compression is inevitable. Your brand deserves better.

The Technology

Proprietary Fermentation Science — How We Build It

Akums' postbiotic formulation begins with precision-controlled fermentation — producing a rich bioactive matrix of metabolites your gut uses directly, without colonisation.

Select Strain

Select Strain

Clinically validated bacterial strains chosen for metabolite output profile.

Ferment

Ferment

Precision-controlled anaerobic fermentation under GMP conditions.

Inactivate

Inactivate

Live bacteria deactivated while preserving bioactive metabolites.

Standardise

Standardise

SCFAs, peptides, and enzymes quantified batch-wise.

Formulate

Formulate

Sachet, capsule, tablet, or gummy — your format, our compliance.

Postbiotic Bioactive
Core Bioactive Components

Precision-Fermented Compounds Built for Gut & Immune Performance

Our postbiotic platform delivers clinically relevant metabolites and functional compounds produced during controlled fermentation — supporting gut integrity, immune modulation, microbial balance, and gastrointestinal resilience.

Short-Chain Fatty Acids

Butyrate, propionate, and acetate support colonocyte energy and gut barrier strength.

Bioactive Peptides

Fermentation-derived compounds support antimicrobial activity and microbiome stability.

Cell Wall Fragments

Non-viable bacterial components help activate immune recognition pathways naturally.

Exopolysaccharides

Fermentation-derived polysaccharides help nourish beneficial resident bacteria.

Clinical Benefits

What It Actually Delivers
— Four Validated Outcomes

Strengthens Gut Barrier Integrity

Butyrate and the SCFA matrix directly upregulate tight junction proteins (claudin-3, occludin, ZO-1), clinically reducing intestinal permeability. Measured via zonulin reduction in controlled trials. Leaky gut — addressed at the molecular level.

Tight junction proteins ↑ · Zonulin ↓

Reduces Bloating & IBS Symptoms

Statistically significant reduction in abdominal distension, flatulence, and cramping within the first 7 days. IBS Symptom Severity Score (IBS-SSS) reduction of 40%+ observed in 8-week trials. No laxative effect, no disruption to stool transit.

IBS-SSS ↓40% in 8 weeks

Activates Immune Cells — NK Cells & IgA

Cell wall fragments stimulate mucosal dendritic cells via TLR/NOD receptors, triggering Natural Killer (NK) cell proliferation and secretory IgA synthesis in gut-associated lymphoid tissue (GALT). Direct immune activation — not dependent on colonisation.

NK cell + sIgA activation in 2 hours

Starts Working Within 2 Hours

Unlike probiotics requiring 2–4 weeks of colonisation before any benefit is measurable, postbiotic bioactives are immediately bioavailable upon ingestion. Immune marker elevation detectable within 2 hours via serum analysis. This changes the consumer experience narrative entirely.

168× faster than probiotics
THE SCIENCE

Probiotics vs Postbiotics — The honest comparison

Postbiotics are bioactive metabolites produced during fermentation — the compounds your gut actually uses. They work immediately, without colonisation, and without a live organism.

Parameter ✕ Probiotics (Old Era) ✦ Postbiotics (New Era)
Time to Effect ✕ 2–4 weeks lag ✓ As fast as 2 hours
Gastric Acid Stability ✕ Live cultures destroyed ✓ Fully stable — non-viable
Cold Chain Required ✕ Refrigeration needed ✓ Ambient stable
Immune Cell Activation ✕ Colonisation-dependent ✓ Direct NK + IgA activation
Gut Barrier Integrity ✕ Inconsistent evidence ✓ Clinically validated
Supply Chain Complexity ✕ Cold chain + expiry risk ✓ Ambient + 24-month shelf
SPEED OF ACTION — TIME TO CLINICALLY MEASURABLE EFFECT
2–4 weeks (336+ hours)
2 hours

↓ Postbiotic delivers results 168× faster than a typical probiotic colonisation cycle.

B2B Opportunity

Akums' proprietary fermentation science transforms gut health innovation into a scalable, compliant, and clinically proven product line — ready to expand your brand portfolio.

The postbiotic category is at the exact inflection point probiotics were in 2010. First-movers will own the category premium, prescriber mindshare, and channel distribution. That window is measured in months, not years.

01

Turnkey CDMO Platform

From active ingredient to finished dosage — sachet, capsule, tablet, gummy. One partner, full regulatory compliance, GMP facility.

02

India's First FSSAI Approval

India's first postbiotic with explicit FSSAI approval — a defensible regulatory moat competitors cannot replicate overnight.

03

Superior Unit Economics

No cold chain means lower COGS, reduced inventory risk, and stronger margins by design.

Who Should Talk To Us

If you're building the next gut health brand

Pharma Nutraceutical Brands

Pharma & Nutraceutical Brands

Upgrade gut health SKUs from commodity probiotics to clinically differentiated, FSSAI-approved postbiotic lines.

Wellness D2C Brands

Wellness & D2C Brands

Build premium gut health products with a strong clinical narrative, ambient shelf life, and fast-acting benefits.

Hospital Clinical Nutrition

Hospital & Clinical Nutrition

Ideal for post-surgical gut repair, ICU microbiome restoration, and antibiotic-associated dysbiosis support.

The gut health category is about to be rewritten.
Own the first chapter.

If you're a health, nutraceutical, or wellness brand looking to launch the next high-margin SKU — this is the conversation to have.

Your brand. Our science. India's first.

Request Formulation Brief → Download Clinical Dossier